Pulmonx Corporation (LUNG) Tops Q2 EPS by 2c

Pulmonx Corporation (NASDAQ: LUNG) reported Q2 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $23.86 million versus the consensus estimate of $23.47 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trump: GDP growth should be 12% to 13% - CNBC interview
• Crusoe in talks to raise $3B in funding - Bloomberg